English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Piramal Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

53/100
200.29
1.31 (0.66%)

As on 05 Sep, 2025 | 03:23

Open Trading A/c
Day Range
199.76
202.49
L H
52 Week Range
181.73
307.90
L H
Volume
2,563,712
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
590 200.05 200.30 1694
2400 200.00 200.35 600
4242 199.95 200.40 109
239 199.90 200.45 561
214 199.85 200.50 399
146726 Total Total 217439
Bid / Ask
200.05 / 200.30
Advance Chart
53/100
200.40
1.40 (0.70%)

As on 05 Sep, 2025 | 03:23

Open Trading A/c
Day Range
199.65
202.45
L H
52 Week Range
180.35
307.85
L H
Volume
164,080
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
590 200.05 200.30 1694
2400 200.00 200.35 600
4242 199.95 200.40 109
239 199.90 200.45 561
214 199.85 200.50 399
146726 Total Total 217439
Bid / Ask
200.05 / 200.30
Advance Chart
53/100
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Bid / Ask
/
Advance Chart
53/100
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Bid / Ask
/
Advance Chart
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 200.39
          Previous Close 198.98
          Volume 2,563,485.00
          Value (Lacs) 5,134.40
            VWAP 200.87
          Beta
          Mkt Cap (Rs. Cr.) 26,624
          High 202.49
          Low 199.76
          UC Limit 218.87
          LC Limit 179.08
          52 Week High 307.90
          52 Week Low 181.73
          Face Value 10.00
          All Time High 307.90
          All Time Low 63.10
          20D Avg Volume 4,236,915
          20D Avg Delivery(%) 31.42
          Book Value Per Share 59.53
          Dividend Yield 0.07
          TTM EPS See historical trend 0.74 (+254.07% YoY)
          TTM PE See historical trend 270.66 (Average PE)
          P/B See historical trend 3.37 (Average P/B)
          Sector PE 39.40

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          53/100
          Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 34.98% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 34.95% to 34.86% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          2 out of 3 years Piramal Pharma has given positive returns in September.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          September 21.18% (2024) 15.19% -0.44% (2023) -0.44% 9.98%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 50% BUY
          • 50% SELL
          • 0% HOLD
          50%
          of moneycontrol users recommend buying Piramal Pharma

          What's your call on Piramal Pharma today?

          Read 1 investor views

          BUY SELL HOLD
          POST

          Broker Research

          29 Jul, 2025

          ICICI Securities

          Reco Price 205.65 Target Price 265
          29 Jul, 2025

          Motilal Oswal

          Reco Price 205.65 Target Price 240
          15 May, 2025

          ICICI Securities

          Reco Price 208.55 Target Price 280
          15 May, 2025

          Motilal Oswal

          Reco Price 208.55 Target Price 250
          24 Oct, 2024

          Motilal Oswal

          Reco Price 256.40 Target Price 310
          25 Sep, 2024

          Motilal Oswal

          Reco Price 226.45 Target Price 260
          Show More
          REFINITIV Report

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          20 Feb, 2025

          Graviton Research Capital Llp

          Qty 6856958 Price 219.7 % Traded 0.52
          20 Feb, 2025

          Graviton Research Capital Llp

          Qty 6856958 Price 219.88 % Traded 0.52

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Piramal Pharma 200.88 0.95 26,701.94 271.46 3.37 1.12 -8.52 18 9,151 0.58
          Sun Pharma 1,594.70 0.78 382,621.95 36.89 5.54 15.13 -12.69 10,980 52,578 0.03
          Divis Labs 6,020.00 -1.85 159,812.09 69.30 11.65 14.63 17.56 2,191 9,360 0.00
          Cipla 1,554.70 -1.46 125,581.53 23.29 4.43 16.90 -4.49 5,291 27,547 0.00
          Torrent Pharma 3,580.10 -0.53 121,166.85 60.53 16.15 25.17 4.00 1,911 11,516 0.40
          + See More

          About the Company

          Data is not Available
          {"success":1,"data":{"address":{"address1":"Ground Floor, Piramal Ananta,","address2":"Agastya Corporate Park,,Kamani Junction,","city":"Mumbai","state":"Maharashtra","pincode":"400070","telephone1":"022-38023000","telephone2":"022-38024000","fax1":"022-","fax2":"","email":"shareholders.ppl@piramal.com","web":"http:\/\/www.piramalpharma.com"},"management":[{"name":"Nandini Piramal","designation":"Chairperson"},{"name":"Peter DeYoung","designation":"Executive Director"},{"name":"Vivek Valsaraj","designation":"Executive Director & CFO"},{"name":"Nathalie Leitch","designation":"Non Executive Director"},{"name":"S Ramadorai","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"543635","nseId":"PPLPHARMA","series":"EQ","isinid":"INE0DK501011"}}}

          • Registered Office

          • Registrars

          • Management

            • Nandini Piramal

              Chairperson

            • Peter DeYoung

              Executive Director

            • Vivek Valsaraj

              Executive Director & CFO

            • Nathalie Leitch

              Non Executive Director

            • S Ramadorai

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              543635

            • NSE:

              PPLPHARMA

            • Series

              EQ

            • ISIN

              INE0DK501011

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347